Dr. Mueller earned his MD at the University of Bonn (Germany) and completed his residency training in Psychiatry at the Charité University Clinic in Berlin. He has then been appointed as Professor at the University of Toronto (Departments of Psychiatry and Pharmacology), and as senior Clinician Scientist at the Centre for Addiction and Mental Health (CAMH) in Toronto since 2008. He is Head of the Pharmacogenetics Research Clinic at CAMH which is one of the first of its kind worldwide to implement pharmacogenetics in clinical practice for antidepressant and antipsychotic medications.
Throughout his career, his overall research goals have been to investigate genetic causes of response and side effects to psychiatric medications on which he published more than 200 articles. This line of research aims to significantly improve treatment of psychiatric conditions and to lessen the burden of medication side effects and to avoid adverse drug-drug interactions. In addition, he is actively involved in developing pharmacogenetics treatment recommendations for physicians and patients through close collaborations with international partners and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
For further details, please see also http://research.camh.net/pgx/